UCB stock gains 0.97 percent after-hours to EUR 203.95
Published on 10/07/2026 at 18:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
UCB stock rose to EUR 203.95 in after-hours trading at 6:30 p.m. CEST on October 7, 2026, up 0.97 percent versus the prior close at Lang & Schwarz.
UCB trading details
The Lang & Schwarz prior close was EUR 202.00. The current bid was EUR 203.50, while the ask stood at EUR 204.40. UCB is listed on Euronext Brussels under the symbol UCB. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of UCB stock.
Recent clinical-data context
In a September 29, 2026 release distributed by PR Newswire, UCB said it would present data from its generalized myasthenia gravis portfolio at the AANEM Annual Meeting and MGFA Scientific Session, including analyses involving zilucoplan and rozanolixizumab and interim data on investigational cizutamig; the release said the safety and efficacy of cizutamig had not been established and that it was not approved by any health authority.
